Bionik Laboratories Corp. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Bionik Laboratories Corp. annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate from 2011 to 2022.
  • Bionik Laboratories Corp. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2022 was $0.000.
  • Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$224K, a 1690% decline from 2021.
  • Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$12.5K.
  • Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $0.000.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.